The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors

Circulation Research

Volumn 110, Issue 8, 2012, Pages

  Papac Milicevic, Nikolina ^a,b   Breuss, Johannes M ^a   Zaujec, Jan ^a   Ryban, Lubos ^a   Plyushch, Tatiana ^a   Wagner, Gabriel A ^a   Fenzl, Sabine ^a   Dremsek, Paul ^a   Cabaravdic, Muris ^a   Steiner, Marianne ^c   Glass, Christopher K ^d   Binder, Christoph J ^a,b   Uhrin, Pavel ^a   Binder, Bernd R ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c Medical University of Vienna   (Austria)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

inflammation; NR4A1; restenosis; vascular injury

Indexed keywords

EXPORTIN 1; INTERFERON REGULATORY FACTOR; INTERFERON STIMULATED GENE 12 PROTEIN; NUCLEAR RECEPTOR NR4A3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; MOUSE; NEOINTIMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VASCULITIS; WILD TYPE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CAROTID ARTERY INJURIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEEDBACK, PHYSIOLOGICAL; FEMORAL ARTERY; GENE EXPRESSION REGULATION; INFLAMMATION; INTERFERONS; KARYOPHERINS; MEMBRANE PROTEINS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; VASCULAR SYSTEM INJURIES;

EID: 84859893900     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.258814     Document Type: Article

References (62)

1. Huang W, Glass CK. Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance. Arterioscler Thromb Vasc Biol. 2010;30:1542-1549.
2. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. Dopamine neuron agenesis in nurr1-deficient mice. Science. 1997;276: 248-250. (Pubitemid 27172681)
3. Bonta PI, van Tiel CM, Vos M, Pols TW, van Thienen JV, Ferreira V, Arkenbout EK, Seppen J, Spek CA, van der PT, Pannekoek H, De Vries CJ. Nuclear receptors nur77, nurr1, and nor-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol. 2006;26:2288-2294. (Pubitemid 44465724)
4. Nomiyama T, Zhao Y, Gizard F, Findeisen HM, Heywood EB, Jones KL, Conneely OM, Bruemmer D. Deficiency of the nr4a neuron-derived orphan receptor-1 attenuates neointima formation after vascular injury. Circulation. 2009;119:577-586.
5. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK. A nurr1/corest pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell. 2009;137:47-59.
6. Zhao Y, Howatt DA, Gizard F, Nomiyama T, Findeisen HM, Heywood EB, Jones KL, Conneely OM, Daugherty A, Bruemmer D. Deficiency of the nr4a orphan nuclear receptor nor1 decreases monocyte adhesion and atherosclerosis. Circ Res. 2010;107:501-511.
7. Hanna RN, Carlin LM, Hubbeling HG, Nackiewicz D, Green AM, Punt JA, Geissmann F, Hedrick CC. The transcription factor nr4a1 (nur77) controls bone marrow differentiation and the survival of ly6c(-) monocytes. Nat Immunol. 2011;12:778-785.
8. Oita RC, Mazzatti DJ, Lim FL, Powell JR, Merry BJ. Whole-genome microarray analysis identifies upregulation of nr4a nuclear receptors in muscle and liver from diet-restricted rats. Mech Ageing Dev. 2009;130: 240-247.
9. Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, Tontonoz P. Nr4a orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med. 2006;12:1048-1055. (Pubitemid 44353386)
10. De Vries CJ, van Achterberg TA, Horrevoets AJ, ten Cate JW, Pannekoek H. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells: local expression in atherosclerotic lesions of SMAGs, smooth muscle activation-specific genes. J Biol Chem. 2000;275:23939-23947. (Pubitemid 30627460)
11. Gruber F, Hufnagl P, Hofer-Warbinek R, Schmid JA, Breuss JM, Huber-Beckmann R, Lucerna M, Papac N, Harant H, Lindley I, de Martin R, Binder BR. Direct binding of nur77/nak-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha-induced PAI-1 expression. Blood. 2003;101:3042-3048. (Pubitemid 36857993)
12. Pei L, Castrillo A, Chen M, Hoffmann A, Tontonoz P. Induction of nr4a orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem. 2005;280:29256-29262. (Pubitemid 41161379)
13. Pei L, Castrillo A, Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor nur77. Mol Endocrinol. 2006;20:786-794.
14. Sohn YC, Kwak E, Na Y, Lee JW, Lee SK. Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor nur77. J Biol Chem. 2001;276:43734-43739.
15. Rambaud J, Desroches J, Balsalobre A, Drouin J. Tif1beta/kap-1 is a coactivator of the orphan nuclear receptor ngfi-b/nur77. J Biol Chem. 2009;284:14147-14156.
16. Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 2006;20:1405-1428. (Pubitemid 43830648)
17. Wansa KD, Harris JM, Muscat GE. The activation function-1 domain of nur77/nr4a1 mediates trans-activation, cell specificity, and coactivator recruitment. J Biol Chem. 2002;277:33001-33011. (Pubitemid 34984815)
18. Wansa KD, Harris JM, Yan G, Ordentlich P, Muscat GE. The af-1 domain of the orphan nuclear receptor nor-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine. J Biol Chem. 2003;278:24776-24790. (Pubitemid 37548635)
19. Wansa KD, Muscat GE. Trap220 is modulated by the antineoplastic agent 6-mercaptopurine, and mediates the activation of the nr4a subgroup of nuclear receptors. J Mol Endocrinol. 2005;34:835-848. (Pubitemid 40903605)
20. Katagiri Y, Hirata Y, Milbrandt J, Guroff G. Differential regulation of the transcriptional activity of the orphan nuclear receptor NGFI-B by membrane depolarization and nerve growth factor. J Biol Chem. 1997; 272:31278-31284. (Pubitemid 28013259)
21. Hermanson O, Glass CK, Rosenfeld MG. Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab. 2002;13: 55-60. (Pubitemid 36740447)
22. Kang SA, Na H, Kang HJ, Kim SH, Lee MH, Lee MO. Regulation of nur77 protein turnover through acetylation and deacetylation induced by p300 and hdac1. Biochem Pharmacol. 80:867-873.
23. Kagaya S, Ohkura N, Tsukada T, Miyagawa M, Sugita Y, Tsujimoto G, Matsumoto K, Saito H, Hashida R. Prostaglandin a2 acts as a transactivator for nor1 (nr4a3) within the nuclear receptor superfamily. Biol Pharm Bull. 2005;28:1603-1607. (Pubitemid 41324116)
24. Chintharlapalli S, Burghardt R, Papineni S, Ramaiah S, Yoon K, Safe S. Activation of nur77 by selected 1,1-bis(3′-indolyl)-1-(p- substitutedphenyl) methanes induces apoptosis through nuclear pathways. J Biol Chem. 2005; 280:24903-24914. (Pubitemid 40934582)
25. Zhan Y, Du X, Chen H, et al. Cytosporone B is an agonist for nuclear orphan receptor nur77. Nat Chem Biol. 2008;4:548-556.
26. Kim HJ, Kim JY, Lee SJ, Oh CJ, Choi YK, Lee HJ, Do JY, Kim SY, Kwon TK, Choi HS, Lee MO, Park IS, Park KG, Lee KU, Lee IK. Alpha-lipoic acid prevents neointimal hyperplasia via induction of p38 mitogen-activated protein kinase/nur77-mediated apoptosis of vascular smooth muscle cells and accelerates postinjury reendothelialization. Arterioscler Thromb Vasc Biol. 2010;30:2164-2172.
27. Arkenbout EK, de WV, van Bragt M, van Achterberg TA, Grimbergen JM, Pichon B, Pannekoek H, De Vries CJ. Protective function of transcription factor tr3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in tr3 transgenic mice. Circulation. 2002;106: 1530-1535.
28. de WV, Arkenbout EK, Vos M, Mocking AI, Niessen HW, Stooker W, de Mol BA, Quax PH, Bakker EN, VanBavel E, Pannekoek H, De Vries CJ. Tr3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. Am J Pathol. 2006;168:2027-2035. (Pubitemid 43825321)
29. Christ G, Seiffert D, Hufnagl P, Gessl A, Wojta J, Binder BR. Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cells. Blood. 1993;81:1277-1283. (Pubitemid 23067365)
30. Leroyer AS, Isobe H, Leseche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A, Boulanger CM. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol. 2007;49:772-777. (Pubitemid 46240708)
31. Prager GW, Mihaly J, Brunner PM, Koshelnick Y, Hoyer-Hansen G, Binder BR. Urokinase mediates endothelial cell survival via induction of the x-linked inhibitor of apoptosis protein. Blood. 2009;113:1383-1390.
32. Leksa V, Godar S, Schiller HB, Fuertbauer E, Muhammad A, Slezakova K, Horejsi V, Steinlein P, Weidle UH, Binder BR, Stockinger H. TGFbeta-induced apoptosis in endothelial cells mediated by m6p/igfii-r and mini-plasminogen. J Cell Sci. 2005;118:4577-4586. (Pubitemid 41556353)
33. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ. A cooperative interaction between NF-kappa b and sp1 is required for HIV-1 enhancer activation. EMBO J. 1993;12:3551-3558. (Pubitemid 23256442)
34. Baker A, Saltik M, Lehrmann H, Killisch I, Mautner V, Lamm G, Christofori G, Cotten M. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther. 1997;4:773-782. (Pubitemid 27380159)
35. Maira M, Martens C, Philips A, Drouin J. Heterodimerization between members of the nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol Cell Biol. 1999;19:7549-7557. (Pubitemid 29493418)
36. Prager GW, Breuss JM, Steurer S, Mihaly J, Binder BR. Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-upa) activation on the surface of endothelial cells. Blood. 2004;103:955-962. (Pubitemid 38129556)
37. Konig P, Krasteva G, Tag C, Konig IR, Arens C, Kummer W. FRET-CLSM and double-labeling indirect immunofluorescence to detect close association of proteins in tissue sections. Lab Invest. 2006;86: 853-864. (Pubitemid 44100483)
38. Hachet-Haas M, Converset N, Marchal O, Matthes H, Gioria S, Galzi JL, Lecat S. FRET and colocalization analyzer: a method to validate measurements of sensitized emission FRET acquired by confocal microscopy and available as an ImageJ plug-in. Microsc Res Tech. 2006;69:941-956. (Pubitemid 44888237)
39. Kronke G, Bochkov VN, Huber J, Gruber F, Bluml S, Furnkranz A, Kadl A, Binder BR, Leitinger N. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of camp-responsive element-binding protein. J Biol Chem. 2003;278:51006-51014. (Pubitemid 38020334)
40. Gilchrist JS, Pierce GN. Identification and purification of a calciumbinding protein in hepatic nuclear membranes. J Biol Chem. 1993;268: 4291-4299. (Pubitemid 23072970)
41. Uhrin P, Dewerchin M, Hilpert M, Chrenek P, Schofer C, Zechmeister-Machhart M, Kronke G, Vales A, Carmeliet P, Binder BR, Geiger M. Disruption of the protein c inhibitor gene results in impaired spermatogenesis and male infertility. J Clin Invest. 2000;106:1531-1539. (Pubitemid 32038590)
42. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 1997;17:2238-2244. (Pubitemid 28057127)
43. Xu Y, Arai H, Zhuge X, Sano H, Murayama T, Yoshimoto M, Heike T, Nakahata T, Nishikawa S, Kita T, Yokode M. Role of bone marrowderived progenitor cells in cuff-induced vascular injury in mice. Arterioscler Thromb Vasc Biol. 2004;24:477-482. (Pubitemid 38326141)
44. Breuss JM, Cejna M, Bergmeister H, Kadl A, Baumgartl G, Steurer S, Xu Z, Koshelnick Y, Lipp J, de MR, Losert U, Lammer J, Binder BR. Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation. 2002; 105:633-638. (Pubitemid 34123440)
45. Ebner K, Bandion A, Binder BR, de MR, Schmid JA. GMCSF activates NF-kappaB via direct interaction of the GMCSF receptor with ikappaB kinase beta. Blood. 2003;102:192-199. (Pubitemid 36759654)
46. Hofer-Warbinek R, Schmid JA, Mayer H, Winsauer G, Orel L, Mueller B, Wiesner C, Binder BR, de MR. A highly conserved proapoptotic gene, ikip, located next to the apaf1 gene locus, is regulated by p53. Cell Death Differ. 2004;11:1317-1325. (Pubitemid 39591777)
47. Martensen PM, Sogaard TMM, Gjermandsen IM, Buttenschon HN, Rossing AB, Bonnevie-Nielsen V, Rosada C, Simonsen JL, Justesen J. The interferon alpha induced protein isg12 is localized to the nuclear membrane. Eur J Biochem. 2001;268:5947-5954. (Pubitemid 33079331)
48. Chen IH, Huber M, Guan T, Bubeck A, Gerace L. Nuclear envelope transmembrane proteins (NETs) that are upregulated during myogenesis. BMC Cell Biol. 2006;7:38.
49. Prokocimer M, Davidovich M, Nissim-Rafinia M, Wiesel-Motiuk N, Bar DZ, Barkan R, Meshorer E, Gruenbaum Y. Nuclear lamins: key regulators of nuclear structure and activities. J Cell Mol Med. 2009;13: 1059-1085.
50. Katagiri Y, Takeda K, Yu ZX, Ferrans VJ, Ozato K, Guroff G. Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat Cell Biol. 2000;2:435-440.
51. Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, Lin B, Chen G, Lu J, Lin F, Xie Z, Fontana JA, Reed JC, Zhang X. Cytochrome C release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor tr3. Science. 2000;289:1159-1164. (Pubitemid 30650723)
52. Cao X, Liu W, Lin F, Li H, Kolluri SK, Lin B, Han YH, Dawson MI, Zhang XK. Retinoid x receptor regulates nur77/tr3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. Mol Cell Biol. 2004;24:9705-9725. (Pubitemid 39458800)
53. Gjermandsen IM, Justesen J, Martensen PM. The interferon-induced gene isg12 is regulated by various cytokines as the gene 6-16 in human cell lines. Cytokine. 2000;12:233-238. (Pubitemid 30449880)
54. Harmon KJ, Couper LL, Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol. 2000;156: 1741-1748. (Pubitemid 30646711)
55. Engelse MA, Arkenbout EK, Pannekoek H, de Vries CJ. Activin and tr3 orphan receptor: two 'atheroprotective' genes as evidenced in dedicated mouse models. Clin Exp Pharmacol Physiol. 2003;30:894-899. (Pubitemid 37506158)
56. Tsukada S, Iwai M, Nishiu J, Itoh M, Tomoike H, Horiuchi M, Nakamura Y, Tanaka T. Inhibition of experimental intimal thickening in mice lacking a novel G-protein-coupled receptor. Circulation. 2003;107: 313-319. (Pubitemid 36135230)
57. Crawford PA, Sadovsky Y, Woodson K, Lee SL, Milbrandt J. Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice. Mol Cell Biol. 1995;15:4331-4316.
58. Lee SL, Wang Y, Milbrandt J. Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transplantation factor NGFI-A (EGR1). Mol Cell Biol. 1996;16:4566-4572. (Pubitemid 26251258)
59. Martensen PM, Justesen J. Small ISGs coming forward. J Interferon Cytokine Res. 2004;24:1-19. (Pubitemid 38152967)
60. Platanias LC. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5:375-386.
61. Hamers AA, Vos M, Rassam F, van Gorp PJ, de Winther MP, Gijbels MJ, de Waard V, de Vries CJ. Bone marrow-specific deficiency of nuclear receptor nur77 enhances atherosclerosis. Circ Res. 2012;110:428-438.
62. Hanna RN, Shaked I, Hubbeling HG, Punt JA, Wu R, Herrley E, Zaugg C, Pei H, Geissmann F, Ley K, Hedrick CC. Nr4a1 (nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res. 2012;110:416-427.